Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity. (Q51932759)
Jump to navigation
Jump to search
scientific article published in September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity. |
scientific article published in September 2006 |
Statements
1 reference
Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity. (English)
1 reference
1 reference
Josep Domingo-Domenech
1 reference
Cristina Oliva
1 reference
Ana Rovira
1 reference
Jordi Codony-Servat
1 reference
Xavier Filella
1 reference
Clara Montagut
1 reference
Marian Tapia
1 reference
Clara Campás
1 reference
Lenny Dang
1 reference
Mark Rolfe
1 reference
Jeffrey S Ross
1 reference
Pere Gascon
1 reference
Joan Albanell
1 reference
Begoña Mellado
1 reference
1 September 2006
1 reference
12
1 reference
18
1 reference
5578-5586
1 reference
Identifiers
1 reference